Medix Inc.

As of March 31, 2026, Medix Inc. carries a market capitalization of 3.64B, placing it among publicly traded companies globally. Its enterprise value stands at 529.95M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Medix Inc.'s next confirmed earnings release is scheduled for November 10, 2026.

As of March 31, 2026, Medix Inc. has 7.67M shares outstanding.

These figures are as of March 31, 2026.

As of March 31, 2026, Medix Inc. maintains a current ratio of 2.19, meaning it holds 2.2x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended March 31, 2026.

As of the close on October 22, 2026, Medix Inc.'s stock has declined approximately 9.89% over the past 52 weeks. The 50-day moving average sits at 485.16, while the 200-day moving average is 491.75.

As of March 31, 2026, Medix Inc. holds 4.06B in cash and equivalents against 825.29M in total debt, resulting in a net debt position of -3.25B. Total book value stands at 3.44B, with working capital of 3.67B providing operational flexibility.